BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25062884)

  • 1. Autoimmune pancreatitis type-1 associated with intraduct papillary mucinous neoplasm: report of two cases.
    Vaquero EC; Salcedo MT; Cuatrecasas M; De León H; Merino X; Navarro S; Ginès A; Abu-Suboh M; Balsells J; Fernández-Cruz L; Molero X
    Pancreatology; 2014; 14(4):316-8. PubMed ID: 25062884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraduct papillary mucinous neoplasm of the pancreas: a tumour linked with IgG4-related disease?
    Bateman AC; Culver EL; Sommerlad M; Chetty R
    J Clin Pathol; 2013 Aug; 66(8):671-5. PubMed ID: 23596150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal papillary mucinous neoplasm of the pancreas and IgG4-related disease: a coincidental association.
    Tabata T; Kamisawa T; Hara S; Kuruma S; Chiba K; Kuwata G; Fujiwara T; Egashira H; Koizumi S; Endo Y; Koizumi K; Fujiwara J; Arakawa T; Momma K; Horiguchi S; Hishima T; Kurata M; Honda G; Kloppel G
    Pancreatology; 2013; 13(4):379-83. PubMed ID: 23890136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of IgG4 response and autoimmune pancreatitis with intraductal papillary-mucinous neoplasms.
    Hedayat AA; Lisovsky M; Suriawinata AA; Longnecker DS
    Pancreatology; 2017; 17(2):263-266. PubMed ID: 28215485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune pancreatitis presenting a short narrowing of main pancreatic duct with subsequent progression to diffuse pancreatic enlargement over 24 months; natural history of autoimmune pancreatitis.
    Umemura S; Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Hori Y; Kato A; Ohara H; Joh T
    JOP; 2014 May; 15(3):261-5. PubMed ID: 24865539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune pancreatitis mimicking an intra-ductal papillary mucinous neoplasm of the pancreas: an original case].
    Kraemer A; Lewin M; Balladur P; Mourra N; Tiret E; Paye F
    Gastroenterol Clin Biol; 2008; 32(6-7):635-9. PubMed ID: 18355996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance.
    Deshpande V; Gupta R; Sainani N; Sahani DV; Virk R; Ferrone C; Khosroshahi A; Stone JH; Lauwers GY
    Am J Surg Pathol; 2011 Jan; 35(1):26-35. PubMed ID: 21164284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexisting Type 1 Autoimmune Pancreatitis and Mixed-type Intraductal Papillary Mucinous Neoplasm.
    Hirano K; Itoi T; Sasahira N; Koyama H; Ihara F
    Intern Med; 2021 Sep; 60(17):2793-2797. PubMed ID: 33746160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
    Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
    Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
    PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment.
    Chang MC; Jan IS; Liang PC; Jeng YM; Yang CY; Tien YW; Wong JM; Chang YT
    J Cyst Fibros; 2015 Sep; 14(5):661-7. PubMed ID: 25869325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center.
    Lanzillotta M; Belli LI; Belfiori G; Palumbo D; Schiavo-Lena M; Capurso G; Arcidiacono PG; Dagna L; Falconi M; Crippa S; Della-Torre E
    Pancreatology; 2024 May; 24(3):456-462. PubMed ID: 38448348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal papillary mucinous neoplasm (IPMN) and chronic pancreatitis: overlapping pathological entities? Two case reports.
    Petrou A; Papalambros A; Brennan N; Prassas E; Margariti T; Bramis K; Rozemberg T; Papalambros E
    JOP; 2011 Jan; 12(1):50-4. PubMed ID: 21206103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary tumors with pancreatic counterparts.
    Nakanuma Y; Sudo Y
    Semin Diagn Pathol; 2017 Mar; 34(2):167-175. PubMed ID: 28109714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pancreatitis-related cholecystitis: a morphologically and immunologically distinctive form of lymphoplasmacytic sclerosing cholecystitis.
    Wang WL; Farris AB; Lauwers GY; Deshpande V
    Histopathology; 2009 Jun; 54(7):829-36. PubMed ID: 19635102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
    Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
    Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune pancreatitis: a systemic immune complex mediated disease.
    Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
    Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraductal papillary mucinous neoplasm and acute pancreatitis.
    Venkatesh PG; Navaneethan U; Vege SS
    J Clin Gastroenterol; 2011 Oct; 45(9):755-8. PubMed ID: 21602701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal serum pancreatic enzymes, but not pancreatitis, are associated with an increased risk of malignancy in patients with intraductal papillary mucinous neoplasms.
    Roch AM; Parikh JA; Al-Haddad MA; DeWitt JM; Ceppa EP; House MG; Nakeeb A; Schmidt CM
    Surgery; 2014 Oct; 156(4):923-9. PubMed ID: 25239347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.